|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/14/12 China-Biotics, Inc 10-K 3/31/12 44:3.1M Toppan Merrill/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 747K
3: EX-21.1 Subsidiaries List HTML 13K
2: EX-16.3 Letter re: Change in Certifying Accountant HTML 15K
4: EX-31.1 Certification -- §302 - SOA'02 HTML 18K
5: EX-31.2 Certification -- §302 - SOA'02 HTML 18K
6: EX-32.1 Certification -- §906 - SOA'02 HTML 14K
7: EX-32.2 Certification -- §906 - SOA'02 HTML 15K
27: R1 Document and Entity Information HTML 43K
20: R2 Consolidated Balance Sheets HTML 126K
25: R3 Consolidated Balance Sheets [Parenthetical] HTML 37K
29: R4 Consolidated Statements of Operations and Other HTML 102K
Comprehensive Income
40: R5 Consolidated Statements of Changes in HTML 39K
Stockholders' Equity
21: R6 Consolidated Statements of Cash Flows HTML 128K
24: R7 Organization and Description of Business HTML 23K
19: R8 Summary of Principal Accounting Policies HTML 57K
16: R9 Earnings Per Share HTML 28K
41: R10 Risks, Uncertainties, and Concentrations HTML 24K
31: R11 Accounts Receivable HTML 19K
30: R12 Inventories HTML 19K
35: R13 Loan Receivable HTML 18K
36: R14 Deposits HTML 23K
34: R15 Land Use Right HTML 26K
37: R16 Property, Plant and Equipment HTML 25K
26: R17 Amount Due to Director HTML 17K
28: R18 Loans Payable HTML 18K
33: R19 Convertible Notes Payable HTML 22K
44: R20 Income Taxes Payable HTML 54K
38: R21 Treasury Stock HTML 18K
22: R22 Capital and Statutory Reserves HTML 17K
32: R23 Option Incentive Plan HTML 34K
23: R24 Product Return Concessions HTML 18K
15: R25 Retirement Costs HTML 27K
39: R26 Commitments and Contingencies HTML 38K
42: R27 Business Segments HTML 38K
18: R28 Schedule I Condensed Parent Company Financial HTML 52K
Statements
43: XML IDEA XML File -- Filing Summary XML 55K
17: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 297K
8: EX-101.INS XBRL Instance -- chbt-20120331 XML 456K
10: EX-101.CAL XBRL Calculations -- chbt-20120331_cal XML 97K
11: EX-101.DEF XBRL Definitions -- chbt-20120331_def XML 177K
12: EX-101.LAB XBRL Labels -- chbt-20120331_lab XML 413K
13: EX-101.PRE XBRL Presentations -- chbt-20120331_pre XML 251K
9: EX-101.SCH XBRL Schema -- chbt-20120331 XSD 69K
14: ZIP XBRL Zipped Folder -- 0001144204-12-051520-xbrl Zip 63K
Exhibit 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO
RULE 15d-14(a) (17 CFR 240.15d-14(a))
(AUTHORIZED BY SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002)
I, Song Jinan, certify that:
1. I have reviewed this Annual Report on Form 10-K of China-Biotics, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
| /s/ Song Jinan | |
| Song Jinan | |
| Chief Executive Officer | |
| September 14, 2012 | |
C:
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 9/14/12 | |||
| For Period end: | 3/31/12 | NT 10-K | ||
| List all Filings | ||||